Antaros Medical is very happy to be part of the PREFERENCE (Exploring Extended Field of View PET for Precision Medicine) consortium and Doctoral Network, which has now been awarded by the European Reseach Executive Agency.
Long axial field of view (LAFOV) postitron emission tomography (PET) systems, sometimes called ‘total body PET scanners’, offer a much larger field of view (FOV) than conventional scanners, and therby have more detectors. This significantly increases sensitivity, which can in turn reduce the required radioactive doses needed for participants or patients, and introduces the possibility of detecting signal dynamics over an extended time window. The extended FOV also facilitates research of systemic diseases by studying multiple organs simultaneously. As these LAFOV PET scanners are newer and not as widely available, it is very important that research into methods and establishing best practices is done to ensure the insights provided can be used in the best way.
The PREFERENCE consortium, through methodological and clinical research projects, aims to fully exploit the benefits of LAFOV PET/CT. This includes methodological research into automated image analysis for advanced metabolic phenotyping in obesity and diabetes, which will be led by Antaros Medical, and will recruit a PhD candidate at Uppsala University. You can read more about PET imaging in metabolic diseases in this blog post.
More information on the PREFERENCE consortium can be found on the project’s website: https://preference-consortium.eu/